We are live on ! Find out more
IART icon

Integra LifeSciences
IART

223 hedge funds and large institutions have $1.57B invested in Integra LifeSciences in 2024 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 78 increasing their positions, 69 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,790% more call options, than puts

Call options by funds: $13.4M | Put options by funds: $345K

26% more capital invested

Capital invested by funds: $1.24B → $1.57B (+$329M)

13% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 69

3% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 40

0.82% less ownership

Funds ownership: 90.69% → 89.87% (-0.82%)

1% less funds holding

Funds holding: 225 → 223 (-2)

Holders
223
Holders Change
-2
Holders Change %
-0.89%
% of All Funds
2.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
41
Increased
78
Reduced
69
Closed
40
Calls
$13.4M
Puts
$345K
Net Calls
+$13.1M
Net Calls Change
+$2.84M

Top Buyers

1
RCMNY
Rubric Capital Management (New York)
New York
+$50.8M
2
SCM
Soleus Capital Management
Connecticut
+$27.9M
3
PCMI
Paradigm Capital Management Inc
New York
+$19.7M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$13.5M
5
Norges Bank
Norges Bank
Norway
+$7.64M

Top Sellers

1
SHCM
Sachem Head Capital Management
New York
-$44.2M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.2M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$9.68M
4
Fisher Asset Management
Fisher Asset Management
Washington
-$7.69M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
-$7.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFM
251
Catalyst Funds Management
Australia
– -$32.7K -1,800 Closed
AAP
252
Arax Advisory Partners
Colorado
– -$15.9K -873 Closed
ACM
253
Aster Capital Management
United Arab Emirates
– -$11K -605 Closed
ST
254
Smithfield Trust
Pennsylvania
– -$3K -120 Closed
RTL
255
Red Tortoise LLC
Georgia
– -$1.13K -62 Closed
JFGIW
256
Johnson Financial Group Inc (Wisconsin)
Wisconsin
– -$1.11K -61 Closed
T
257
Tidemark
California
– -$799 -44 Closed
SWM
258
Spire Wealth Management
Virginia
– -$636 -35 Closed
MFG
259
Mendota Financial Group
Wisconsin
– -$110 -6 Closed
CA
260
Claris Advisors
Missouri
– -$73 -4 Closed
SIC
261
SJS Investment Consulting
Ohio
– -$55 -3 Closed
DPW
262
DiNuzzo Private Wealth
Pennsylvania
– -$37 -2 Closed
N
263
Natixis
France
– -$18 -1 Closed
7 8 9 10
11

IART Hedge Fund Activity: Q4 2024 in Review

223 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2024, worth a combined $1.57B — up 26% from $1.24B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new IART positions and 40 closed out — a net gain of 1 holder — while 78 added to existing stakes and 69 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $50.8M. The largest seller was Sachem Head Capital Management, exiting entirely with an estimated $44.2M sold.

  • 223 institutional investors held Integra LifeSciences (IART) as of Q4 2024, down from 225 in Q3 2024.
  • Funds reported $1.57B of Integra LifeSciences stock for Q4 2024, up 26% quarter-over-quarter.
  • 41 funds opened new Integra LifeSciences positions in Q4 2024 and 40 closed out, a net change of +1 holder.
  • The largest Integra LifeSciences buyer in Q4 2024 was Rubric Capital Management (New York), an estimated $50.8M added.
  • The largest Integra LifeSciences seller in Q4 2024 was Sachem Head Capital Management, an estimated $44.2M sold.

Based on aggregated 13F filings for Q4 2024.